Bayer AG
XETRA:BAYN
Bayer AG
Long-Term Investments
Bayer AG
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Long-Term Investments
€3.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Long-Term Investments
$91.7m
|
CAGR 3-Years
125%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Long-Term Investments
€984m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
29%
|
|
MPH Health Care AG
XETRA:93M1
|
Long-Term Investments
€193.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Long-Term Investments
€76m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Long-Term Investments
€2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Long-Term Investments?
Long-Term Investments
3.1B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Long-Term Investments amounts to 3.1B EUR.
What is Bayer AG's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
8%
Over the last year, the Long-Term Investments growth was 6%. The average annual Long-Term Investments growth rates for Bayer AG have been 15% over the past three years , 3% over the past five years , and 8% over the past ten years .